Moderna, Inc. (FRA:0QF)
21.00
-0.81 (-3.71%)
Dec 1, 2025, 8:26 PM CET
Moderna Employees
Moderna had 5,800 employees as of December 31, 2024. The number of employees increased by 200 or 3.57% compared to the previous year.
Employees
5,800
Change (1Y)
200
Growth (1Y)
3.57%
Revenue / Employee
€327,989
Profits / Employee
€457,891
Market Cap
8.12B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5,800 | 200 | 3.57% |
| Dec 31, 2023 | 5,600 | 1,700 | 43.59% |
| Dec 31, 2022 | 3,900 | 1,200 | 44.44% |
| Dec 31, 2021 | 2,700 | 1,400 | 107.69% |
| Dec 31, 2020 | 1,300 | 470 | 56.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 59,020 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,528 |
| Carl Zeiss Meditec AG | 5,730 |
Moderna News
- 14 hours ago - What's Going On With Moderna Stock Monday? - Benzinga
- 15 hours ago - Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men - Market Watch
- 16 hours ago - Top Stock Movers Now: Coinbase, Robinhood, Moderna, Synopsys, and More - Investopedia
- 16 hours ago - Moderna (MRNA) Shares Drop Amid Stricter FDA Vaccine Approval Standards - GuruFocus
- 17 hours ago - Moderna, vaccine makers decline following FDA official comments on future approvals - Seeking Alpha
- 18 hours ago - Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths - Investor's Business Daily
- 18 hours ago - Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals - Barrons
- 19 hours ago - Stocks making the biggest moves premarket: Synopsys, Moderna, Micron Technology, Wynn Resorts, Coinbase and more - CNBC